Table 3.

Properties of the 14 isolates obtained from the blood samples of 6 patients.

Patient	Isolate ID	Resistant against	Intermediate to	Antibiotic resistance phenotype	qacA/B	smr	MIC of disinfectants % (w/w)			MLVA type
							CHG-A	ISP-QAC	QAC-B
1	1a	RIF, OXA	TE	S	-	-	0.0976	0.195	0.003	11
	1b	ERY, CLI, GM, OXA	TE, CIP	S	-	-	0.0244	0.195	≤0.000375	Non-typeable
2	2a	TS, CLI	-	S	+	-				17
	2b	TS, ERY	-	S	-	-	0.006	0.0244	≤0.000375	18
	2c	TS	VAN	S	-	-	0.006	0.0122	≤0.000375	19
3	3a	TE, TS, OXA	VAN	MDR	-	-	≤0.000375	≤0.000375	≤0.000375	27
	3b	ERY, TE, CTS, OXA	-	MDR	-	-	0.00075	≤0.000375	≤0.000375	28
							0.00075	≤0.000375	≤0.000375
4	4a	CIP, GAT, TS, OXA	VAN	MDR	-	+	0.006	0.0976	≤0.000375	31
	4b	CIP, GAT, TS, OXA	-	MDR	-	+	0.0122	0.195	≤0.000375	32
5	5a	ERY, CLI, CIP, GAT, TS, GM, OXA	-	S	-	-	0.0122	0.0488	≤0.000375	36
	5b	CLI, CIP, GAT, TS, OXA	VAN	MDR	+	-	0.0976	0.0244	≤0.000375	37
6	6a	TS	-	S	-	+	0.0122	0.0244	≤0.000375	41
	6b	ER, CLI, CIP, RIF, GAT, TE, TS, GM, OXA	VAN	MDR	+	-	0.0244	0.0976	≤0.000375	42

ERY: erythromycin, CLI: clindamycin, SYN: synercid (quinupristin/dalfopristin), CIP: ciprofloxacin, RIF: rifampin, GAT: gatifloxacin, TE: tetracycline, TS: co-trimoxazole, GM: gentamicin, OXA: oxacillin, VAN: vancomycin; MDR: multidrug resistant

CHG-A: 0.5% (w/w) chlorhexidine digluconateand 75% (w/w) alcohol; ISP-QAC: 70% (w/w) isopropanol and 0.25% (w/w) Quaternary ammonium compounds (QACs); QAC-B: QACs and biguanides